TABLE 1.

Clinical characteristics of seven EICU patients infected with IRPA^a

Case	Isolate	Gender/age (yr)	Length of hospitalization (days)	Day of isolation	Diagnosis	Antibiotic(s) administered	Outcome
1	85	Male/78	>365	40	Obstructive pulmonary emphysema	Ceftazidime, levofloxacin, ertapenem	Improvement
2	373	Male/73	7	17	Pneumonia, II respiratory failure, pulmonary encephalopathy	Amikacin, ciprofloxacin, imipenem, piperacillin-tazobactam, azithromycin, roxithromycin	Improvement
3	483	Male/40	107	39	Primary brain stem injury	Teicoplanin, amikacin, meropenem, voriconazole	Improvement
4	599	Male/83	24	11	Obstructive pulmonary emphysema II respiratory failure	cefoperazone-sulbactam, teicoplanin, amikacin	Death
5	2703	Male/82	17	7	Lung aspiration pneumonia	Meropenem, teicoplanin	Cured
6	2860	Male/80	38	30	Obstructive pulmonary emphysema	Meropenem	Improvement
7	2876	Male/70	24	15	Extensive abdominal abscess	Meropenem, amikacin	Cured

^aThese 7 patients all experienced ventilator, deep-vein catheterization, and a urine catheter in the EICU. All patients had mixed infections after P. aeruginosa was isolated the first time. The most common pathogens isolated from mixed infection were methicillin-resistant Staphylococcus aureus, A. baumannii, E. coli, Klebsiella pneumoniae, and Candida albicans.